Q2 FY2026 EarningsQ2 FY2026 results showed a modest revenue beat of $94.5M vs. $92.8M expected (+1.8% variance), driven by strong demand for robotic system sales (+30% YoY). Gross margin outperformed consensus at 66.0% vs. 65.1%, aided by a one-time tariff refund. Despite the top-line strength, GAAP EPS missed slightly at -$0.47 vs. -$0.46 expected, as aggressive SG&A spending to expand the commercial infrastructure offset the revenue gains and margin expansion.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: PROCEPT BioRobotics(PRCT) the Revenue is 94.5 M (+19.34%), Beat estimate;the EBIT is -27.39 M (-23.44%), Miss estimate;the EPS is -0.47 (-34.29%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.09B19.34%
0.09B17.22%
+0.00B2.12%
EBITMiss expectations
-0.03B23.44%
-0.03B22.78%
-0.00B0.66%
EPSMiss expectations
-0.4734.29%
-0.461931.97%
-0.00812.32%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf